Trogenix is currently owned by 4Bio Partners, through 4BIO Ventures III, since 2023.

When did 4Bio Partners acquire Trogenix?

4Bio Partners acquired Trogenix in 2023 (active for 3 years).

Home/Companies/Biotech/Trogenix

Trogenix

Biotech·

UK·Active·3yr hold

Trogenix is a biotech company, headquartered in UK.

Entry

2023

Hold

3yr

Status

Active

Est. EV

–

Investor

4Bio Partners

Key facts

HQUK

SectorBiotech

StatusActive

Edinburgh-based oncology biotechnology company founded and incubated by 4BIO Capital in 2023 to develop curative therapies for aggressive…Read full notes

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from 4BIO Ventures III

Other portfolio companies in the same fund.

Cytospire Therapeutics

More PE-backed in Biotech

Comparable biotech deals from other GPs.

AdBio PartnersBelgium

Last updated May 2026 · Sourced from public filings